Assessment of resectability of pancreatic cancer using novel immersive high-performance virtual reality rendering of abdominal computed tomography and magnetic resonance imaging - Takeaways - MDSpire

Assessment of resectability of pancreatic cancer using novel immersive high-performance virtual reality rendering of abdominal computed tomography and magnetic resonance imaging

  • By

  • Julia Madlaina Kunz

  • Peter Maloca

  • Andreas Allemann

  • David Fasler

  • Savas Soysal

  • Silvio Däster

  • Marko Kraljević

  • Gulbahar Syeda

  • Benjamin Weixler

  • Christian Nebiker

  • Vincent Ochs

  • Raoul Droeser

  • Harriet Louise Walker

  • Martin Bolli

  • Beat Müller

  • Philippe Cattin

  • Sebastian Manuel Staubli

  • January 22, 2024

  • 0 min

Share

  • 1

    The study evaluates the use of immersive VR technology for assessing the resectability of pancreatic ductal adenocarcinoma (PDAC).

  • 2

    Specto VR™ software enables real-time rendering of CT and MRI data into interactive 3D models for enhanced anatomical understanding.

  • 3

    Current resectability assessment of PDAC relies on 2D imaging, which presents challenges due to low inter-observer agreement.

  • 4

    The study involves clinicians assessing anatomical structures in VR, aiming to improve the accuracy of vascular involvement evaluation.

  • 5

    Ethical approval was obtained, and participants included trained abdominal surgeons and radiologists from multiple institutions.

Original Source(s)

Related Content